Ahmed_2021_Pak.J.Pharm.Sci_34_855

Reference

Title : 1,3-di-4-piperidylpropane derivatives as potential acetyl cholinesterase antagonists: Molecular docking, synthesis, and biological evaluation - Ahmed_2021_Pak.J.Pharm.Sci_34_855
Author(s) : Ahmed A , Akhtar S , Mushtaq N , Haider S , Munawar R , Siddique HA , Akram A , Saify ZS , Arif M
Ref : Pak J Pharm Sci , 34 :855 , 2021
Abstract :

Acetylcholine esterase (AChE) is a key biological target responsible for the management of cholinergic transmission, and its inhibitors are used for the therapy of Alzheimer's disease. In the present study, a small library of molecules with 1,3-di-4-piperidylpropane nucleus were docked on AChE. The selected compounds were synthesized and evaluated for their enzyme inhibition. P25 and P17 expressed significantly higher AChE inhibition than standards with IC50 values of 0.591microM and 0.625microM, respectively. Binding mode of derivatives in the active site of AChE revealed dual binding of molecules in peripheral anionic site (PAS) and catalytic anionic site (CAS) of enzyme cavity.

PubMedSearch : Ahmed_2021_Pak.J.Pharm.Sci_34_855
PubMedID: 34602406

Related information

Citations formats

Ahmed A, Akhtar S, Mushtaq N, Haider S, Munawar R, Siddique HA, Akram A, Saify ZS, Arif M (2021)
1,3-di-4-piperidylpropane derivatives as potential acetyl cholinesterase antagonists: Molecular docking, synthesis, and biological evaluation
Pak J Pharm Sci 34 :855

Ahmed A, Akhtar S, Mushtaq N, Haider S, Munawar R, Siddique HA, Akram A, Saify ZS, Arif M (2021)
Pak J Pharm Sci 34 :855